Archive for October, 2016

By John E. Harris, MD, PhD and Mark Scharf, MD The success of narrowband UVB (311-312) therapy for vitiligo was first reported by Westerhof and Nieuweboer – Krobotova in 1997. Yones et al. reported superiorefficacy of nbUVB over PUVA in 2007. No evidence – based guidelines for treatment have been